AP549A - Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections. - Google Patents

Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections. Download PDF

Info

Publication number
AP549A
AP549A APAP/P/1992/000356A AP9200356A AP549A AP 549 A AP549 A AP 549A AP 9200356 A AP9200356 A AP 9200356A AP 549 A AP549 A AP 549A
Authority
AP
ARIPO
Prior art keywords
quinone
composition
acid
formula
concentration
Prior art date
Application number
APAP/P/1992/000356A
Other languages
English (en)
Other versions
AP9200356A0 (en
Inventor
Washington Odour Ayuko
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of AP9200356A0 publication Critical patent/AP9200356A0/xx
Application granted granted Critical
Publication of AP549A publication Critical patent/AP549A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034—Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038—Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/1992/000356A 1991-02-13 1992-02-12 Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections. AP549A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use

Publications (2)

Publication Number Publication Date
AP9200356A0 AP9200356A0 (en) 1992-04-30
AP549A true AP549A (en) 1996-11-01

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000356A AP549A (en) 1991-02-13 1992-02-12 Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections.

Country Status (30)

Country Link
EP (1) EP0499467A3 (no)
JP (1) JPH06505231A (no)
CN (1) CN1064407A (no)
AP (1) AP549A (no)
AU (2) AU1233992A (no)
BG (1) BG61025B1 (no)
BR (1) BR9205642A (no)
CA (1) CA2104009A1 (no)
CZ (1) CZ166893A3 (no)
DZ (1) DZ1559A1 (no)
FI (1) FI933595A (no)
GB (2) GB9103075D0 (no)
GT (1) GT199200009A (no)
HU (1) HUT65634A (no)
IE (1) IE920464A1 (no)
IL (1) IL100906A (no)
IN (1) IN178929B (no)
IS (1) IS3814A (no)
JO (1) JO1719B1 (no)
LT (1) LT3197B (no)
MA (1) MA22443A1 (no)
MX (1) MX9200622A (no)
MY (1) MY131098A (no)
NO (1) NO932681L (no)
NZ (2) NZ240487A (no)
OA (2) OA09535A (no)
SK (1) SK87993A3 (no)
TN (1) TNSN92015A1 (no)
WO (1) WO1992014454A1 (no)
ZA (1) ZA921037B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
BR9507128A (pt) * 1994-03-17 1997-09-30 Radopath Ltd Composto e composição farmacêutica para tratamento de profilaxia ou terapia de neoplasma ou infecção viral ácido 2- cloro-5-nitrobenzóico processo de preparação de composição farmacêutica processo de tratamento por frofilaxia ou terapia de neoplasma ou infecção viral e processo de tratamento de mamíferos para profilaxia de sarcoma de kaposi
EP0705601B1 (de) * 1994-10-04 2000-01-19 LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik Lösungen von Anthrachinonen zur parenteralen Applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
US8092841B2 (en) 2007-08-08 2012-01-10 Bionovo, Inc. Estrogenic extracts of Ligustrum lucidum ait. of the oleaceae family and uses thereof
JP2010538093A (ja) 2007-09-07 2010-12-09 バイオノボ・インコーポレーテッド シソ科ファミリーのセイタカナミキソウのエストロゲン性抽出物およびその使用
AU2008296072A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
EP2194998A4 (en) 2007-09-07 2012-03-21 Bionovo Inc STROGENIC EXTRACTS OF ASPARAGUS CONCHINCHINENSIS (LOUR.) MERR OF THE LILIACEAE FAMILY AND USES THEREOF
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
EP2222323A4 (en) 2007-11-19 2012-07-25 Bionovo Inc PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON
AU2008326426A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
CA2727018A1 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
US9884815B2 (en) * 2011-10-14 2018-02-06 Emory University PGAM1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
KR20210032405A (ko) * 2018-07-17 2021-03-24 삘리 안트라퀴논 유도체 및 착색제로서의 그의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5643210A (en) * 1979-09-18 1981-04-21 Koutaku Hayashi Immunity enhancing, drug resistance preventive and carcinostatic agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA774443B (en) * 1977-07-22 1978-06-28 Allied Chem Anthrquinone compounds as anti-cancer agents
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
WO1989005141A1 (en) * 1987-12-10 1989-06-15 Tsumura Juntendo, Inc. Anti-retroviral drug
HU208624B (en) * 1988-08-16 1993-12-28 Wellcome Found Process for producing pharmaceutical compositions containing naphtoquinone derivatives effective against pneumocystis infections
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
EP0524212A1 (en) * 1990-04-03 1993-01-27 Radopath Limited Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5643210A (en) * 1979-09-18 1981-04-21 Koutaku Hayashi Immunity enhancing, drug resistance preventive and carcinostatic agent

Also Published As

Publication number Publication date
GB9103075D0 (en) 1991-03-27
OA09810A (en) 1994-04-15
GT199200009A (es) 1993-08-06
CA2104009A1 (en) 1992-08-14
TNSN92015A1 (fr) 1993-06-08
GB9203084D0 (en) 1992-03-25
IE920464A1 (en) 1992-08-12
FI933595A0 (fi) 1993-08-13
SK87993A3 (en) 1993-12-08
LT3197B (en) 1995-03-27
GB2254554B (en) 1995-09-20
JPH06505231A (ja) 1994-06-16
CZ166893A3 (en) 1994-03-16
BG61025B1 (bg) 1996-09-30
ZA921037B (en) 1992-11-25
OA09535A (en) 1992-11-15
WO1992014454A1 (en) 1992-09-03
EP0499467A3 (en) 1992-12-16
AU1233992A (en) 1992-09-15
IL100906A0 (en) 1992-11-15
CN1064407A (zh) 1992-09-16
MX9200622A (es) 1992-11-01
LTIP329A (en) 1994-08-25
NZ240487A (en) 1994-03-25
IL100906A (en) 1996-09-12
DZ1559A1 (fr) 2002-02-17
NZ241593A (en) 1995-05-26
EP0499467A2 (en) 1992-08-19
IS3814A (is) 1992-08-14
MA22443A1 (fr) 1992-10-01
FI933595A (fi) 1993-08-13
HUT65634A (en) 1994-07-28
JO1719B1 (en) 1992-12-15
AP9200356A0 (en) 1992-04-30
NO932681L (no) 1993-10-07
NO932681D0 (no) 1993-07-26
BR9205642A (pt) 1994-06-21
GB2254554A (en) 1992-10-14
BG98041A (bg) 1994-05-27
MY131098A (en) 2007-07-31
IN178929B (no) 1997-07-19
AU5590696A (en) 1996-08-08
HU9302347D0 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
AP549A (en) Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections.
AU2001230977B2 (en) Combinations for treating neoplasms
Schultz Case study: high-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney
AU2001230977A1 (en) Combinations for treating neoplasms
BG63612B1 (bg) Състав и метод за профилактика и лечение на нiv идруги инфекциозни заболявания при човека
Hellmann et al. Preliminary clinical assessment of ICRF 159 in acute leukaemia and lymphosarcoma
Strommen et al. Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment
JP2011516478A (ja) 免疫療法のための組成物および方法
EP0281380A2 (en) Synergistic interplay of interleukin-2 and dsRNAs
US6720011B1 (en) Injectable composition for cancer treatment
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
OA12862A (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone.
JP2020537689A (ja) Ａ−ノル−５αアンドロスタン化合物を含む白血球増多製剤およびその使用
Desimone et al. Tetrahydrouridine, cytidine analogues, and hemoglobin F
HRP920891A2 (en) Quinone preparation
AU651998B2 (en) Use of a retinoid
KR102576410B1 (ko) 바실러스 균주와 5-fu를 유효성분으로 하는 대장암 치료용 약학 조성물
Slevin et al. The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspension
EP0874630A1 (en) Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy
KR20020026743A (ko) 비소화합물 및 글루타치온 고갈 유도 화합물을 함유하는항암조성물
CN117243963A (zh) Remodelin与Venetoclax在治疗癌症中的应用
JPH05221868A (ja) 食細胞貪食能賦活剤
CZ2014517A3 (cs) Farmaceutický prostředek s virucidním a antibakteriálním účinkem
MXPA97000190A (en) Chemioprevention of colorectal polipos adenomatosos metacrono